3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
10
Leukemia, Myeloid, Acute
9
Hodgkin Disease
8
Lymphoma, Non-Hodgkin
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Multiple Myeloma
5
Lymphoma, Large B-Cell, Diffuse
5
Small Cell Lung Carcinoma
4
Sarcoma
4
Recurrence
4
Neuroblastoma
4
Central Nervous System Neoplasms
4
Lymphoma, T-Cell
3
Lymphoma, B-Cell
3
Carcinoma, Non-Small-Cell Lung
3
Burkitt Lymphoma
3
Teratoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Optic Nerve Glioma
2
Oligodendroglioma
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Immunoblastic Lymphadenopathy
2
Congenital Abnormalities
2
Breast Neoplasms
2
Interventions
antineoplaston AS 2-1
3
antineoplaston A10
3
dactolisib
2
Temozolomide
2
Irinotecan
2
Everolimus
2
Bevacizumab
2
surufatinib
1
spartalizumab
1
poly ICLC
1
plerixafor
1
pasireotide
1
fosbretabulin
1
cixutumumab
1
adavosertib
1
Vaccines
1
TH 302
1
Sunitinib
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation
1
PM 00104
1
Lapatinib
1
Immunologic Techniques
1
Immunoglobulin G
1
Genistein
1
Fentanyl
1
Donepezil
1
Disulfides
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroectodermal Tumors, Primitive
×
etoposide phosphate
×
Clear all
No trials found.